NYSE • Healthcare • Medical - Instruments & Supplies • US • USD
Becton, Dickinson and Company (BDXB) has a consensus analyst rating of Buy, based on 30 analysts covering the stock. Of those, 16 recommend buying, 13 recommend holding, and 1 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
